Yes — but with strict eligibility criteria that mean most UK adults currently access Mounjaro through private pathways. As of June 2025, NHS England began rolling out Mounjaro through GP services for the highest-need patients: those with the highest BMI and the most weight-related health conditions. The rollout is staged over 12 years, meaning NHS access will remain limited for most eligible adults for years to come. This is the honest 2026 guide to NHS eligibility, what’s actually available, and your realistic options.
For private access costs: Mounjaro Cost UK and Cheapest Mounjaro Provider UK. For eligibility context: Am I Eligible for Mounjaro UK.
The current NHS situation (2026)
NICE approved tirzepatide (Mounjaro) for weight management in December 2024, recommending it for adults with a BMI of 35 or above plus at least one weight-related comorbidity, or for those with lower BMI in certain ethnic groups where health risk thresholds differ.
NHS England committed to a phased rollout over 12 years — the longest phased implementation of any NICE-approved medication. As of June 2025, Cohort 1 (the highest-need patients) began accessing Mounjaro through GP services in England. As of mid-2026, the rollout continues slowly through specialist weight management services and some GP practices.
What this means practically: most adults who would benefit from Mounjaro do not currently qualify for NHS prescribing, even if they meet NICE clinical criteria. The 12-year timeline means the NHS pipeline will remain constrained throughout this decade.
Who qualifies for NHS Mounjaro (Cohort 1 criteria)
The initial NHS rollout prioritises:
- BMI 40+ with at least one significant weight-related comorbidity (type 2 diabetes, hypertension, obstructive sleep apnea, cardiovascular disease)
- BMI 35–40 with type 2 diabetes specifically AND other risk factors suggesting urgent need
- Lower BMI thresholds apply for people from South Asian, Chinese, Black African, Black Caribbean, or other high-risk ethnic backgrounds (usually BMI 5 units lower than the standard threshold)
These thresholds are likely to expand as subsequent cohorts open, but no confirmed timeline exists for broader access.
How to access NHS Mounjaro
If you think you may qualify:
- Book a GP appointment. Explain your weight, BMI, and any weight-related health conditions. Ask your GP to assess whether you meet current NHS eligibility criteria for tirzepatide.
- Request a referral to a tier-3 weight management service if your GP cannot prescribe directly. Specialist weight management services have slightly broader access than GP prescribing in some regions.
- Check your local integrated care board (ICB) guidance. NHS availability varies by region. Some ICBs have implemented faster rollouts; others lag significantly. Your GP can advise on local provision.
- Ask about alternatives. If you don’t meet Mounjaro criteria, you may qualify for Wegovy (semaglutide), which has slightly different NICE approval criteria and has been available through some NHS services since 2023.
What “specialist weight management services” means
The NHS uses a tier system for weight management:
- Tier 1: public health resources (website info, apps, general advice)
- Tier 2: structured weight loss programmes (Slimming World via GP referral, NHS 12-week plan)
- Tier 3: specialist multi-disciplinary weight management services — dietitian, psychologist, physician. Mounjaro is increasingly available here.
- Tier 4: bariatric surgery services
Tier 3 services typically have waiting lists of 6–18 months in most regions. Referral is via your GP. If you’re placed on a waiting list, private treatment in the interim is an option some patients choose — with the intention to transfer care to NHS once a place becomes available.
NHS vs private: the honest comparison
| NHS | Private | |
|---|---|---|
| Cost per month | Prescription charge only (~£9.90 per item) | £150–£330 depending on dose and provider |
| Access timeline | Months to years waiting | Typically 1–2 weeks from consultation |
| Eligibility | Strict criteria, Cohort 1 only currently | Broader criteria, assessed by provider |
| Clinical oversight | Full NHS care pathway | Provider-dependent; quality varies |
| Supply reliability | NHS supply chain | Private market subject to shortages |
See NHS GLP-1 vs Private UK for a fuller comparison of both routes.
Scotland, Wales, and Northern Ireland
NHS access differs by devolved nation:
Scotland: SMC (Scottish Medicines Consortium) approved tirzepatide; Scottish NHS access is via specialist weight management services. Similar cohort-based rollout to England but administered differently through health boards.
Wales: AWMSG (All Wales Medicines Strategy Group) approval in place. Access through specialist services; GP prescribing less common than in England.
Northern Ireland: historically behind England and Scotland for weight management medication access. The first specialist weight management services are planned to open in 2026 but as of mid-2026, NHS access to Mounjaro in Northern Ireland is extremely limited.
What to do if you don’t qualify for NHS Mounjaro
Three realistic paths:
1. Private prescription. The most common route for UK adults who need treatment now. See Mounjaro Cost UK for a full provider comparison and current pricing.
2. Lose weight to qualify for bariatric surgery. Counter-intuitive, but some patients use private Mounjaro to reach the NHS bariatric surgery weight threshold, then transition to surgical treatment on the NHS. Discuss with your GP if bariatric surgery is appropriate for your situation.
3. Continue advocating. NHS criteria are likely to expand over time. Maintaining a GP relationship that documents your weight-related health conditions means you’re positioned to access NHS treatment when criteria broaden to include your profile.
Checking your BMI and eligibility
The NHS BMI calculator provides your current BMI. Remember that BMI thresholds are adjusted downward for South Asian, Chinese, Black African, and Black Caribbean ethnicity — if this applies to you, discuss adjusted thresholds with your GP.
BMI alone isn’t the only consideration — the number and severity of weight-related comorbidities matters as much as the BMI figure for current NHS prescribing decisions.
Frequently asked questions
Can my GP prescribe Mounjaro on the NHS?
Yes, from June 2025 — but only for patients meeting Cohort 1 eligibility criteria (BMI 40+ with comorbidities, or lower BMI with type 2 diabetes and significant risk factors). Many GPs are still unfamiliar with the full prescribing pathway; bringing the NICE guidance to your appointment helps.
How long is the waiting list for NHS Mounjaro?
For tier-3 specialist services, typically 6–18 months in most regions. Direct GP prescribing for Cohort 1 patients can be faster where GP practices have implemented the pathway.
Is Wegovy available on the NHS instead?
Wegovy (semaglutide) has been available through some NHS specialist services since 2023 with slightly different criteria to Mounjaro. If you’re enquiring about NHS weight management medication, ask about both. See Saxenda vs Wegovy UK for the full picture.
Can I switch from private to NHS once eligible?
In principle yes. Your private prescriber can provide clinical information for your GP to support the transition. In practice, NHS prescribing capacity may mean a wait even when you meet criteria. Discuss with your GP.
Does having type 2 diabetes improve my chances of NHS Mounjaro?
Yes — Mounjaro is also licensed as a diabetes medication, and NHS diabetes prescribing has different (often broader) criteria than the weight management pathway. Your GP can assess whether prescribing for diabetes management is appropriate alongside weight loss goals.
Medical disclaimer: NHS eligibility criteria change as rollout progresses. Always confirm current local criteria with your GP. This guide reflects the position as understood in mid-2026.
How to make the most of private treatment while waiting for NHS access
If you’re on a waiting list or don’t yet meet NHS criteria, private treatment can be used strategically — not just as a stopgap. Some specific approaches:
Document everything. Keep records of your private prescriptions, weight loss progress, and any health improvements (blood pressure readings, HbA1c if tested). This creates a clinical evidence trail that strengthens your case when NHS criteria broaden to include your profile.
Track your nutrition and progress rigorously. Using Cronometer during private treatment demonstrates adherence and metabolic improvement — data that supports a compelling case when transitioning to NHS care. GPs respond better to “I’ve lost 18kg and reduced my HbA1c from 58 to 43 mmol/mol over eight months” than to “I’ve been on it privately and it’s working.”
Maintain your GP relationship throughout. Regular updates to your GP about your Mounjaro treatment, even when it’s private, keeps them informed and positions you well for the NHS transition. Some GPs will advocate on your behalf with specialist services once they see documented clinical benefit.
Time your NHS eligibility conversation. When your BMI reaches the threshold or when new cohorts open, having a recent appointment history with your GP discussing weight management means you’re positioned to access NHS treatment quickly rather than starting from scratch.
Frequently asked questions
Can my GP prescribe Mounjaro on the NHS?
From June 2025, yes — but only for patients meeting Cohort 1 eligibility criteria (BMI 40+ with comorbidities, or lower BMI with type 2 diabetes and significant risk factors). Many GPs are still familiarising themselves with the full prescribing pathway; bringing the NICE guidance (TA1026) reference to your appointment can help.
How long is the waiting list for NHS Mounjaro?
For tier-3 specialist services, typically 6–18 months in most regions. Direct GP prescribing for Cohort 1 patients can be faster where GP practices have implemented the pathway — call your surgery and ask specifically about weight management medication prescribing.
Is Wegovy available on the NHS instead?
Wegovy (semaglutide) has been available through some NHS specialist services since 2023 with slightly different criteria to Mounjaro. If you’re enquiring about NHS weight management medication, ask about both. Some patients who don’t meet Mounjaro criteria may meet Wegovy criteria. See Saxenda vs Wegovy UK.
Can I switch from private to NHS once eligible?
In principle yes, and your private prescriber can provide clinical documentation to support the transition. In practice, NHS prescribing capacity may mean a wait even when you meet criteria — the transition takes planning, not just eligibility.
Does having type 2 diabetes improve my chances of NHS Mounjaro?
Yes — Mounjaro is also licensed as a diabetes medication, and NHS diabetes prescribing has different (often broader) criteria than the weight management pathway. Your GP can assess whether prescribing for diabetes management is appropriate alongside your weight loss goals, which may open an NHS route that weight management criteria alone wouldn’t.
Discover more from Healthy Weight Loss GLP1
Subscribe to get the latest posts sent to your email.
